Clinical trial for Hypertension
Official title A Study of IBI3016 in Japanese Participants
ClinicalTrials.gov ID: NCT07838220
What this study is testing
What is IBI3016 Dose 4?
IBI3016 Dose 4 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for hypertension.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A phase I clinical study to evaluate the safety ,tolerability, pharmacokinetic and pharmocodynamic characteristics of a single subcutaneous does of IBI3016 in Japanese participants with mild to moderate hypertension.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- 1\. Male or female participants aged 18-75 years (inclusive) at the time of informed consent;
- 2\. Must have been born in Japan, and their biological parents and grandparents must have been of Japanese origin;
- 3\. Office mean sitting SBP≥ 140 mmHg and \< 170 mmHg at screening
You likely can't join if
- 1\. Participants with secondary hypertension, including but not limited to the following conditions: obstructive sleep apnea;
- 2\. History of orthostatic hypotension
- 3\. Current or history of intolerance to AECI, ARB, ARNI or direct renin inhibitor
- 4\. With diseases that require treatment with renin-angiotensin-aldosterone system (RAAS) inhibitors other than hypertension at screening;
- 5\. Presence of serious active and uncontrolled physical conditions or medical history, which may be in a dangerous state during the use of the study...
The study team makes the final eligibility decision.
Where it's taking place
- Osaka, Japan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Osaka, Japan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.